Annual Current Assets
$3.23 B
+$276.34 M+9.35%
December 31, 2024
Summary
- As of February 26, 2025, BMRN annual total current assets is $3.23 billion, with the most recent change of +$276.34 million (+9.35%) on December 31, 2024.
- During the last 3 years, BMRN annual current assets has risen by +$958.04 million (+42.12%).
- BMRN annual current assets is now at all-time high.
Performance
BMRN Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$3.23 B
+$175.84 M+5.75%
December 31, 2024
Summary
- As of February 26, 2025, BMRN quarterly total current assets is $3.23 billion, with the most recent change of +$175.84 million (+5.75%) on December 31, 2024.
- Over the past year, BMRN quarterly current assets has increased by +$175.84 million (+5.75%).
- BMRN quarterly current assets is now -0.83% below its all-time high of $3.26 billion, reached on June 30, 2024.
Performance
BMRN Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
BMRN Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.3% | +5.8% |
| 3 y3 years | +42.1% | +13.7% |
| 5 y5 years | +66.4% | +13.7% |
BMRN Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.1% | -0.8% | +42.1% |
| 5 y | 5-year | at high | +66.4% | -0.8% | +66.4% |
| alltime | all time | at high | >+9999.0% | -0.8% | >+9999.0% |
BioMarin Pharmaceutical Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $3.76 B(-3.3%) | $3.23 B(+5.8%) |
| Sep 2024 | - | $3.06 B(-6.2%) |
| Jun 2024 | - | $3.26 B(+9.2%) |
| Mar 2024 | - | $2.99 B(+1.0%) |
| Dec 2023 | $3.89 B(+7.2%) | $2.96 B(+0.0%) |
| Sep 2023 | - | $2.96 B(+0.2%) |
| Jun 2023 | - | $2.95 B(+3.8%) |
| Mar 2023 | - | $2.84 B(+3.3%) |
| Dec 2022 | $3.62 B(-2.9%) | $2.75 B(+2.6%) |
| Sep 2022 | - | $2.68 B(+6.6%) |
| Jun 2022 | - | $2.52 B(+5.2%) |
| Mar 2022 | - | $2.39 B(+5.3%) |
| Dec 2021 | $3.73 B(+6.4%) | $2.27 B(-1.6%) |
| Sep 2021 | - | $2.31 B(-2.0%) |
| Jun 2021 | - | $2.36 B(+3.0%) |
| Mar 2021 | - | $2.29 B(-2.3%) |
| Dec 2020 | $3.51 B(+27.6%) | $2.34 B(-14.5%) |
| Sep 2020 | - | $2.74 B(+3.5%) |
| Jun 2020 | - | $2.65 B(+25.1%) |
| Mar 2020 | - | $2.12 B(+9.0%) |
| Dec 2019 | $2.75 B(+15.9%) | $1.94 B(+4.5%) |
| Sep 2019 | - | $1.86 B(+2.9%) |
| Jun 2019 | - | $1.81 B(-5.7%) |
| Mar 2019 | - | $1.92 B(-6.8%) |
| Dec 2018 | $2.37 B(-2.3%) | $2.06 B(-14.6%) |
| Sep 2018 | - | $2.41 B(+5.6%) |
| Jun 2018 | - | $2.28 B(+1.7%) |
| Mar 2018 | - | $2.24 B(+1.5%) |
| Dec 2017 | $2.43 B(-6.8%) | $2.21 B(+7.7%) |
| Sep 2017 | - | $2.05 B(+40.5%) |
| Jun 2017 | - | $1.46 B(+7.8%) |
| Mar 2017 | - | $1.35 B(-4.9%) |
| Dec 2016 | $2.60 B(-1.4%) | $1.42 B(-14.7%) |
| Sep 2016 | - | $1.67 B(+50.7%) |
| Jun 2016 | - | $1.11 B(+11.4%) |
| Mar 2016 | - | $992.79 M(-8.9%) |
| Dec 2015 | $2.64 B(+144.9%) | $1.09 B(-7.3%) |
| Sep 2015 | - | $1.18 B(-3.2%) |
| Jun 2015 | - | $1.21 B(-20.3%) |
| Mar 2015 | - | $1.52 B(+8.9%) |
| Dec 2014 | $1.08 B(-2.6%) | $1.40 B(+29.7%) |
| Sep 2014 | - | $1.08 B(-11.7%) |
| Jun 2014 | - | $1.22 B(-2.1%) |
| Mar 2014 | - | $1.25 B(+9.6%) |
| Dec 2013 | $1.11 B(+34.2%) | $1.14 B(+59.4%) |
| Sep 2013 | - | $713.48 M(-1.0%) |
| Jun 2013 | - | $720.92 M(-0.3%) |
| Mar 2013 | - | $723.02 M(-2.7%) |
| Dec 2012 | $824.92 M(-1.3%) | $743.43 M(+3.3%) |
| Sep 2012 | - | $719.39 M(+5.6%) |
| Jun 2012 | - | $681.53 M(+32.8%) |
| Mar 2012 | - | $513.39 M(+9.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $835.91 M(+10.2%) | $469.80 M(-3.5%) |
| Sep 2011 | - | $487.02 M(-5.3%) |
| Jun 2011 | - | $514.11 M(+2.0%) |
| Mar 2011 | - | $503.83 M(-0.1%) |
| Dec 2010 | $758.36 M(+68.7%) | $504.26 M(-9.0%) |
| Sep 2010 | - | $554.19 M(+6.2%) |
| Jun 2010 | - | $521.91 M(+4.3%) |
| Mar 2010 | - | $500.43 M(+7.0%) |
| Dec 2009 | $449.44 M(+165.9%) | $467.73 M(-10.1%) |
| Sep 2009 | - | $520.27 M(+2.6%) |
| Jun 2009 | - | $506.98 M(-29.0%) |
| Mar 2009 | - | $713.58 M(-3.3%) |
| Dec 2008 | $169.00 M(-1.2%) | $737.70 M(+5.8%) |
| Sep 2008 | - | $697.01 M(-0.7%) |
| Jun 2008 | - | $701.81 M(+2.6%) |
| Mar 2008 | - | $683.73 M(+6.1%) |
| Dec 2007 | $170.98 M(+32.3%) | $644.30 M(+0.5%) |
| Sep 2007 | - | $641.23 M(+0.0%) |
| Jun 2007 | - | $640.93 M(+99.9%) |
| Mar 2007 | - | $320.64 M(-4.1%) |
| Dec 2006 | $129.21 M(+2.3%) | $334.22 M(-1.5%) |
| Sep 2006 | - | $339.37 M(-1.6%) |
| Jun 2006 | - | $344.81 M(-9.0%) |
| Mar 2006 | - | $378.76 M(+449.4%) |
| Dec 2005 | $126.36 M(-14.5%) | $68.94 M(-16.1%) |
| Sep 2005 | - | $82.19 M(+108.9%) |
| Jun 2005 | - | $39.34 M(-26.6%) |
| Mar 2005 | - | $53.60 M(-37.1%) |
| Dec 2004 | $147.81 M(+375.7%) | $85.16 M(-39.5%) |
| Sep 2004 | - | $140.69 M(-22.5%) |
| Jun 2004 | - | $181.59 M(-13.0%) |
| Mar 2004 | - | $208.82 M(-7.3%) |
| Dec 2003 | $31.07 M(+5.2%) | $225.27 M(-11.4%) |
| Sep 2003 | - | $254.21 M(-7.6%) |
| Jun 2003 | - | $275.05 M(+77.7%) |
| Mar 2003 | - | $154.79 M(+90.9%) |
| Dec 2002 | $29.54 M(-15.7%) | $81.07 M(-11.3%) |
| Sep 2002 | - | $91.37 M(-13.4%) |
| Jun 2002 | - | $105.56 M(-14.5%) |
| Mar 2002 | - | $123.43 M(-9.8%) |
| Dec 2001 | $35.03 M(+8.1%) | $136.78 M(+170.1%) |
| Sep 2001 | - | $50.64 M(-20.4%) |
| Jun 2001 | - | $63.59 M(+77.3%) |
| Mar 2001 | - | $35.86 M(-19.5%) |
| Dec 2000 | $32.39 M(-12.8%) | $44.54 M(-13.4%) |
| Sep 2000 | - | $51.41 M(-4.0%) |
| Jun 2000 | - | $53.53 M(-13.0%) |
| Mar 2000 | - | $61.55 M(-7.3%) |
| Dec 1999 | $37.13 M(+98.4%) | $66.42 M(-13.1%) |
| Sep 1999 | - | $76.40 M(+262.1%) |
| Jun 1999 | - | $21.10 M(+283.6%) |
| Mar 1999 | - | $5.50 M |
| Dec 1998 | $18.71 M | - |
FAQ
- What is BioMarin Pharmaceutical annual total current assets?
- What is the all time high annual current assets for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual current assets year-on-year change?
- What is BioMarin Pharmaceutical quarterly total current assets?
- What is the all time high quarterly current assets for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly current assets year-on-year change?
What is BioMarin Pharmaceutical annual total current assets?
The current annual current assets of BMRN is $3.23 B
What is the all time high annual current assets for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual total current assets is $3.23 B
What is BioMarin Pharmaceutical annual current assets year-on-year change?
Over the past year, BMRN annual total current assets has changed by +$276.34 M (+9.35%)
What is BioMarin Pharmaceutical quarterly total current assets?
The current quarterly current assets of BMRN is $3.23 B
What is the all time high quarterly current assets for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly total current assets is $3.26 B
What is BioMarin Pharmaceutical quarterly current assets year-on-year change?
Over the past year, BMRN quarterly total current assets has changed by +$175.84 M (+5.75%)